Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Sends Rare CDRH Notice-Of-Opportunity-For-Hearing Letter

This article was originally published in The Gray Sheet

Executive Summary

FDA's issuance of a notice-of-opportunity-for-hearing letter (NOOH) to a prominent eye physician indicates the device center is moving forward with administrative procedures to examine whether his clinical investigator (CI) privileges should be revoked
Advertisement

Related Content

FDA Seeking Civil Penalties From Clinical Investigator Disqualified By CDRH
FDA Seeking Civil Penalties From Clinical Investigator Disqualified By CDRH
Advertisement
UsernamePublicRestriction

Register

MT016087

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel